Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

STEPwise De-escalation and Optimizing Withdrawal of ARNI and SGLT2i in Normalized Heart Failure (STEP-DOWN HF Trial)

NCT07631156 is registered in ClinicalTrials.gov with Kyungsub Song as lead sponsor.

NCT NCT07631156
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07631156 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
STEPwise De-escalation and Optimizing Withdrawal of ARNI and SGLT2i in Normalized Heart Failure (STEP-DOWN HF Trial)
Lead sponsor
Kyungsub Song
Phase
Phase 4
Overall status
Recruiting
Start date
August 12, 2026
Completion date
December 30, 2029
Enrollment
80 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure, heart failure with reduced ejection fraction, ventricular dysfunction, left